FGF401

FGF401 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FGF401, covering 2020-12-17 to 2020-12-17. Get the full timeline:

Most recent: Clinical Trial Update: FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression [Phase 1, Phase 2]